In the studies of Liu and Mosleh, although HLA-DR is negative in all control subjects, the expression of other antigens as CD117, CD34, CD11b, CD13, CD33, CD64, and MPO are significantly different between APL and non-APL patients [20, 21]. Here, KIT is linked to acute promyelocytic leukemia.